Dianthus Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-6.5M | $-6.7M | $139.0K | $662.0K |
| FY2017 | $-22.3M | $-24.5M | $2.2M | $2.3M |
| FY2018 | $-41.9M | $-49.6M | $7.7M | $10.7M |
| FY2019 | $-57.1M | $-60.2M | $3.1M | $10.0M |
| FY2020 | $-64.0M | $-64.4M | $400.0K | $9.9M |
| FY2021 | $-59.5M | $-60.8M | $1.3M | $10.3M |
| FY2022 | $-29.1M | $-29.4M | $314.0K | $1.5M |
| FY2023 | $-36.9M | $-36.9M | — | $2.9M |
| FY2024 | $-78.2M | $-78.2M | — | $12.9M |
| FY2025 | $-129.1M | $-129.1M | — | $22.8M |